Indicative Announcement on Change in Equity Structure of Controlling Shareholder
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Indicative Announcement on Change in Equity Structure of Controlling Shareholder
Filed with SSE ·
On 6ix: 6ix.com/news/indicative-announcement-on-change-in-equity-structure-of-controlling-shareholder-3
6ix hasn’t read this filing yet.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. on 6ix
Earlier from Jiangsu Lianhuan Pharmaceutical
- Report for Q3 2025
- Announcement on Adjusting Members of Special Committees
- Announcement on Outline of the 2025 Semi-annual Performance Briefing
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Later from Jiangsu Lianhuan Pharmaceutical
- Announcement on Active Pharmaceutical Ingredient Levonorgestrel Passing the World Health Organization Prequalification On-site Inspection
- Announcement on Completion of Change in the Equity Structure of Indirect Shareholders
- Announcement on Amending the Articles of Association, and Formulating and Revising Some Governance Systems
- Announcement on Adding Extraordinary Proposal to the 4th Extraordinary General Meeting in 2025
- Announcement on Holding Subsidiary Passing Generic Drug Consistency Evaluation
Follow Jiangsu Lianhuan Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Lianhuan Pharmaceutical